Andrew Goldsweig to Fibrinolytic Agents
This is a "connection" page, showing publications Andrew Goldsweig has written about Fibrinolytic Agents.
Connection Strength
0.833
-
Ismayl M, Goldsweig AM. Editorial: Like a kid in a candy shop: Choosing the sweetest therapy for submassive pulmonary embolism. Cardiovasc Revasc Med. 2024 May; 62:82-84.
Score: 0.204
-
Ismayl M, Ismayl A, Hamadi D, Aboeata A, Goldsweig AM. Catheter-directed thrombolysis versus thrombectomy for submassive and massive pulmonary embolism: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2024 Mar; 60:43-52.
Score: 0.201
-
Dobesh PP, Goldsweig AM. Antithrombotic therapy with Transcatheter aortic valve replacement. Pharmacotherapy. 2023 Oct; 43(10):1064-1083.
Score: 0.198
-
Ismayl M, Machanahalli Balakrishna A, Aboeata A, Gupta T, Young MN, Altin SE, Aronow HD, Goldsweig AM. Meta-Analysis Comparing Catheter-Directed Thrombolysis Versus Systemic Anticoagulation Alone for Submassive Pulmonary Embolism. Am J Cardiol. 2022 09 01; 178:154-162.
Score: 0.184
-
Freeman JV, Higgins AY, Wang Y, Du C, Friedman DJ, Daimee UA, Minges KE, Pereira L, Goldsweig AM, Price MJ, Reddy VY, Gibson D, Doshi SK, Varosy PD, Masoudi FA, Curtis JP. Antithrombotic Therapy After Left?Atrial?Appendage Occlusion in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2022 05 10; 79(18):1785-1798.
Score: 0.046